scholarly journals Educational attainment of childhood cancer survivors: A systematic review

2019 ◽  
Vol 8 (6) ◽  
pp. 3182-3195
Author(s):  
Michal Molcho ◽  
Maureen D'Eath ◽  
Audrey Alforque Thomas ◽  
Linda Sharp
2012 ◽  
Vol 58 (5) ◽  
pp. 665-674 ◽  
Author(s):  
Katja. I. Braam ◽  
Annelies Overbeek ◽  
Gertjan J.L. Kaspers ◽  
Cecile M. Ronckers ◽  
Annette Y.N. Schouten-van Meeteren ◽  
...  

2011 ◽  
Vol 19 (9) ◽  
pp. 1275-1287 ◽  
Author(s):  
Anne F. Klassen ◽  
Samantha J. Anthony ◽  
Aalia Khan ◽  
Lillian Sung ◽  
Robert Klaassen

2017 ◽  
Vol 114 ◽  
pp. 131-138 ◽  
Author(s):  
Christina Signorelli ◽  
Claire E. Wakefield ◽  
Joanna E. Fardell ◽  
W. Hamish B. Wallace ◽  
Eden G. Robertson ◽  
...  

2012 ◽  
Vol 60 (3) ◽  
pp. 351-356 ◽  
Author(s):  
Morag Heirs ◽  
Sara Suekarran ◽  
Russell Slack ◽  
Kate Light ◽  
Faith Gibson ◽  
...  

2013 ◽  
Vol 60 (10) ◽  
pp. 1565-1573 ◽  
Author(s):  
Sarah Singer ◽  
Micòl E. Gianinazzi ◽  
Anna Hohn ◽  
Claudia E. Kuehni ◽  
Gisela Michel

2017 ◽  
Vol 41 (5) ◽  
pp. S27 ◽  
Author(s):  
Kiyoka Sasaki ◽  
Amirrtha Srikanthan ◽  
Nancy Baxter ◽  
Iliana Lega

Cancers ◽  
2021 ◽  
Vol 13 (24) ◽  
pp. 6331
Author(s):  
Marco Torella ◽  
Gaetano Riemma ◽  
Pasquale De Franciscis ◽  
Marco La Verde ◽  
Nicola Colacurci

Background: Female childhood cancer survivors (CCS) might have impaired ovarian reserves, especially after alkylating agents or radiotherapy. The purpose of this systematic review and network meta-analysis is to evaluate the role of serum anti-Müllerian hormone (AMH) for ovarian reserve screening and the risk of premature ovarian insufficiency (POI) according to the subtype of childhood cancer. (2) Methods: PRISMA-NMA guidelines were followed. We carried out a network meta-analysis based on a random effects model for mixed multiple treatment comparisons to rank childhood cancers effects on fertility by surface under the cumulative ranking curve (SUCRA). Studies were selected only if they had an age-matched control group. Quality assessment was performed using Newcastle–Ottawa Scale. The co-primary outcomes were mean AMH levels and the incidence of POI. (3) Results: A total of 8 studies (1303 participants) were included. Women treated for a neuroblastoma during infancy were more likely to be ranked first for impaired AMH levels (SUCRA = 65.4%), followed by mixed CCS (SUCRA = 29.6%). The greatest rates of POI were found in neuroblastoma survivors (SUCRA = 42.5%), followed by acute lymphoid leukemia (SUCRA = 26.3%) or any other neoplasia (SUCR A= 20.5%). (4) Conclusions: AMH represents a trustworthy approach for ovarian reserve screening. Direct and indirect comparisons found no differences in mean AMH levels and POI risk between subtypes of CCS and healthy controls. SUCRA analysis showed that female neuroblastoma survivors were more at risk for reduced serum AMH levels and increased risk of POI.


Sign in / Sign up

Export Citation Format

Share Document